icon-    folder.gif   Conference Reports for NATAP  
  Conference on Retroviruses
and Opportunistic Infections
February 12-16, 2022
Back grey_arrow_rt.gif
Asymptomatic SARS-CoV-2 Infection is Extremely Common among People with HIV
  CROI 2022 Feb 11-16
Isabelle R. Weir1 , Edgar T Overton2, Markella V. Zanni3, Stephanie Fischinger4, Kathleen V. Fitch3, Judith A. Aberg5,Carl J. Fichtenbaum6, Gerald S. Bloomfield7, Carlos Malvestutto8,Sara McCallum3,
Pamela S. Douglas7, Galit Alter4, Heather Ribaudo1, Steven K. Grinspoon3, for the REPRIEVE Trial Investigators
1. Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston MA. 2. Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL. 3. Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA. 4. Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA. 5. Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY. 6. Department of Medicine for Translational Research, University of Cincinnati, Cincinnati, OH. 7. Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC,.8. Division of Infectious Diseases, The Ohio State University Wexner Medical Center, Columbus, OH.